Imran N Siddiqi
Overview
Explore the profile of Imran N Siddiqi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li G, Ma B, Zhang S, Liu R, Siddiqi I, Sali A, et al.
Br J Cancer
. 2025 Mar;
PMID: 40044981
Background: PI3K pathway activation is a common and early event in prostate cancer, from loss of function mutations in PTEN, or activating mutations in PIK3Ca or AKT leading to constitutive...
2.
Emerson J, Wang H, Siddiqi I
Am J Clin Pathol
. 2024 Nov;
PMID: 39520696
Objectives: A microfluidic flow cytometer-based point-of-care (POC) analyzer was validated against an in-laboratory hematology analyzer (Sysmex XN Automated Hematology System). Concordance on a full complete blood cell count (CBC) with...
3.
Hagiya A, Siddiqi I, Wang E, Lu C
Am J Clin Pathol
. 2024 Mar;
162(1):28-40.
PMID: 38511841
Objectives: To discuss VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, including the clinical and pathologic features, diagnostic challenges, and treatment options. Methods: A case-based approach and pertinent literature review...
4.
Yau D, Aron M, Siddiqi I
Int J Surg Pathol
. 2018 Nov;
27(2):181-184.
PMID: 30392418
We report an unusual intrasinusoidal growth pattern of an intraabdominal diffuse large B-cell lymphoma both clinically and histologically mimicking a metastatic adenocarcinoma. A 66-year-old woman presented with a high-grade distal...
5.
Piatek C, Vergara-Lluri M, Pullarkat V, Siddiqi I, OConnell C, Brynes R, et al.
Acta Haematol
. 2017 Sep;
138(3):129-137.
PMID: 28866671
Background: Autoimmune myelofibrosis (AIMF) is an underrecognized cause of nonmalignant bone marrow fibrosis which occurs in the presence or absence of a defined systemic autoimmune disease. Patients with AIMF present...
6.
Li P, Siddiqi I, Mottok A, Loo E, Wu C, Cozen W, et al.
J Pathol
. 2017 Jul;
243(2):220-229.
PMID: 28722111
Monoamine oxidase A (MAOA) is a mitochondrial enzyme that catalyzes oxidative deamination of neurotransmitters and dietary amines and produces H O . It facilitates the progression of gliomas and prostate...
7.
Fletcher L, Veenstra R, Loo E, Hwang A, Siddiqi I, Visser L, et al.
PLoS One
. 2017 Mar;
12(3):e0174457.
PMID: 28334025
A proportion of classical Hodgkin lymphomas harbor the Epstein Barr virus (EBV). We previously demonstrated that associations between Human Leukocyte Antigen (HLA) alleles and susceptibility to EBV+ classical Hodgkin lymphoma...
8.
Siddiqi I, Friedman J, Barry-Holson K, Ma C, Thodima V, Kang I, et al.
Mod Pathol
. 2016 Mar;
29(6):570-81.
PMID: 26965583
A predominantly diffuse growth pattern and CD23 co-expression are uncommon findings in nodal follicular lymphoma and can create diagnostic challenges. A single case series in 2009 (Katzenberger et al) proposed...
9.
Dias L, Thodima V, Friedman J, Ma C, Guttapalli A, Mendiratta G, et al.
Leuk Lymphoma
. 2015 Aug;
57(4):899-908.
PMID: 26294112
Genomic copy number alterations (CNAs) in diffuse large B-cell lymphoma (DLBCL) have roles in disease pathogenesis, but overall clinical relevance remains unclear. Herein, an unbiased algorithm was uniformly applied across...
10.
Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature
Vergara-Lluri M, Piatek C, Pullarkat V, Siddiqi I, OConnell C, Feinstein D, et al.
Hum Pathol
. 2014 Oct;
45(11):2183-91.
PMID: 25282037
Autoimmune myelofibrosis (AIMF) is a distinct clinicopathological entity associated with diffuse bone marrow fibrosis and a benign clinical course. Distinction from neoplastic etiologies of marrow fibrosis, particularly primary myelofibrosis, is...